UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
Titel:
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
Auteur:
Hulshof, Emma C. de With, Mirjam de Man, Femke M. Creemers, Geert-Jan Deiman, Birgit A.L.M. Swen, Jesse J. Houterman, Saskia Koolen, Stijn L.W. Bins, Sander Thijs, Anna M.J. Laven, Marjan M.J. Hövels, Anke M. Luelmo, Saskia A.C. Houtsma, Danny Shulman, Katerina McLeod, Howard L. van Schaik, Ron H.N. Guchelaar, Henk-Jan Mathijssen, Ron H.J. Gelderblom, Hans Deenen, Maarten J.